Loading
An Australian cancer epidemiologist whose modelling put a date on cervical cancer elimination in Australia and who was first author of the pilot results of Compass, the trial behind the country's HPV-based screening.
Karen Canfell's 2026 papers give the Cancer Elimination Collaboration at the University of Sydney's School of Public Health as affiliation. Two pieces of work tie the name to Australian cancer policy. As first author of the Compass pilot, run with the VCS Foundation in Victoria, the randomised evidence showed primary HPV screening finding more high-grade precancer than cytology in a population already partly vaccinated. As senior author of the 2019 Lancet Public Health modelling study, with Ian Frazer among the co-authors, the projection was that Australia's cervical cancer incidence could fall below four cases per 100,000 women around 2028, the threshold the national elimination strategy adopted.
It put a date on elimination for the first time in any country, and the threshold it used, four cases per 100,000 women, is the one in the national strategy that aims for elimination by 2035.
It was early randomised evidence that HPV testing still finds more precancer than cytology once a population is partly vaccinated, the question Australia had to answer before changing its national programme to HPV testing every five years.
Shares Ian Frazer, HPV & HBV vaccination, Cervical cancer.
Shares Ian Frazer, HPV & HBV vaccination, Cervical cancer.
Shares Ian Frazer, HPV & HBV vaccination, Cervical cancer.
Shares Ian Frazer, HPV & HBV vaccination, Cervical cancer.
Shares Ian Frazer, HPV & HBV vaccination, Cervical cancer.
Shares Ian Frazer, HPV & HBV vaccination, Cervical cancer.
Shares Ian Frazer, Cervical cancer.
Shares Ian Frazer, HPV & HBV vaccination, Cervical cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/